Monday, November 10, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Strategy Stock: Bitcoin Bet Defies Market Slump

Robert Sasse by Robert Sasse
August 5, 2025
in Stocks
0
Strategy Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Despite reporting record Q2 2025 earnings, MicroStrategy’s shares plunged 9% amid broader crypto-market weakness triggered by a disappointing US jobs report. The software firm surpassed profit expectations, raising its Bitcoin KPI targets for the second time this year and projecting $34 billion in operating income. Analysts maintained bullish outlooks, with one institution lifting its price target to $700, citing growing institutional adoption and regulatory clarity.

Aggressive Accumulation Pays Off

MicroStrategy purchased an additional 21,021 Bitcoin for $2.46 billion in early August, bringing its total holdings to 628,791 BTC ($72 billion at current prices). The company funded the spree through a $2.52 billion preferred stock offering and retains access to billions more via ATM programs. Trading at just 1.64x net asset value—20% below historical averages—the stock appears undervalued given its Bitcoin reserves. Meanwhile, a Japanese firm mirrored the strategy, acquiring 463 BTC, signaling widening institutional interest.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from November 10 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 10.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Simon Property Stock

Simon Property Stock: Soars on Record Earnings and Expansion

Fraport Stock

Fraport Stock: Strong Earnings Defy Revenue Dip

Fresenius Medical Care Stock

Fresenius Medical Care Stock: Mixed Q2 Results Amid Challenges

Recommended

Exploring the Rise of NFT Projects: How Cultural Themes Are Reshaping the Crypto Landscape

2 years ago
Honeywell Stock

Honeywell’s Corporate Split Creates Dual Trading Scenario

3 weeks ago
Apple Stock

Apple Stock: Soars on $100B US Investment and Samsung Chip Deal

3 months ago
Technology Artificial intelligence Market Capitalization

AWS and Nvidia Collaboration Revolutionizing AI Infrastructure and Services

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Rocket Lab Shares Surge Ahead of Quarterly Earnings Report

Fossil’s Fate Hangs in the Balance as Court Decision Looms

Adtalem Shares Plummet Amid Fraud Probe Despite Record Performance

Futu Holdings Poised for Potential Record-Breaking Quarter

Nuclear Renaissance Powers Global X Uranium ETF to New Heights

Genomics Giant Illumina Sees Partial China Market Reopening

Trending

Viking Therapeutics Stock
Earnings

Viking Therapeutics Emerges as Major Contender in Weight-Loss Drug Arena

by Andreas Sommer
November 10, 2025
0

Viking Therapeutics has captured significant market attention following the release of impressive clinical trial results for its...

Eli Lilly Stock

Eli Lilly Shares Surge as Analyst Optimism Reaches New Heights

November 10, 2025
PowerFleet Stock

PowerFleet Shares Surge Following Impressive Quarterly Performance

November 10, 2025
Rocket Lab USA Stock

Rocket Lab Shares Surge Ahead of Quarterly Earnings Report

November 10, 2025
Fossil Stock

Fossil’s Fate Hangs in the Balance as Court Decision Looms

November 10, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics Emerges as Major Contender in Weight-Loss Drug Arena
  • Eli Lilly Shares Surge as Analyst Optimism Reaches New Heights
  • PowerFleet Shares Surge Following Impressive Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com